HK1255631A1 - Pharmaceutical composition for preventing and treating sleep disorders - Google Patents
Pharmaceutical composition for preventing and treating sleep disordersInfo
- Publication number
- HK1255631A1 HK1255631A1 HK18114767.2A HK18114767A HK1255631A1 HK 1255631 A1 HK1255631 A1 HK 1255631A1 HK 18114767 A HK18114767 A HK 18114767A HK 1255631 A1 HK1255631 A1 HK 1255631A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preventing
- pharmaceutical composition
- sleep disorders
- treating sleep
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2016105535A RU2620855C1 (en) | 2016-02-18 | 2016-02-18 | Pharmaceutical composition for sleep disorders prevention and treatment |
PCT/RU2017/000077 WO2017142442A1 (en) | 2016-02-18 | 2017-02-16 | Pharmaceutical composition for preventing and treating sleep disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1255631A1 true HK1255631A1 (en) | 2019-08-23 |
Family
ID=59032329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18114767.2A HK1255631A1 (en) | 2016-02-18 | 2018-11-19 | Pharmaceutical composition for preventing and treating sleep disorders |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20180101539A (en) |
CN (1) | CN108697645A (en) |
BR (1) | BR112018016725A2 (en) |
CL (1) | CL2018002337A1 (en) |
EA (1) | EA201891647A1 (en) |
HK (1) | HK1255631A1 (en) |
MX (1) | MX2018009921A (en) |
RU (1) | RU2620855C1 (en) |
WO (1) | WO2017142442A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1696959A2 (en) * | 2003-12-24 | 2006-09-06 | Sepracor, Inc. | Melatonin combination therapy for improving sleep quality |
EP2717698A4 (en) * | 2011-06-09 | 2015-01-07 | Requis Pharmaceuticals Inc | Antihistamines combined with dietary supplements for improved health |
FR3000896B1 (en) * | 2013-01-14 | 2016-08-26 | Philippe Perovitch | GALENIC FORM FOR ADMINISTRATION OF ACTIVE INGREDIENT (S) FOR ACCELERATED INDUCTION OF SLEEP AND / OR TREATMENT OF SLEEP DISORDERS |
WO2014138162A1 (en) * | 2013-03-05 | 2014-09-12 | Requis Pharmaceuticals Inc. | Preparations for the treatment of sleep-related respiratory disorders |
-
2016
- 2016-02-18 RU RU2016105535A patent/RU2620855C1/en active
-
2017
- 2017-02-16 EA EA201891647A patent/EA201891647A1/en unknown
- 2017-02-16 KR KR1020187023412A patent/KR20180101539A/en not_active Application Discontinuation
- 2017-02-16 BR BR112018016725A patent/BR112018016725A2/en not_active Application Discontinuation
- 2017-02-16 WO PCT/RU2017/000077 patent/WO2017142442A1/en active Application Filing
- 2017-02-16 CN CN201780009565.8A patent/CN108697645A/en active Pending
- 2017-02-16 MX MX2018009921A patent/MX2018009921A/en unknown
-
2018
- 2018-08-16 CL CL2018002337A patent/CL2018002337A1/en unknown
- 2018-11-19 HK HK18114767.2A patent/HK1255631A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2018009921A (en) | 2018-11-09 |
BR112018016725A2 (en) | 2019-04-30 |
WO2017142442A1 (en) | 2017-08-24 |
CL2018002337A1 (en) | 2018-11-30 |
CN108697645A (en) | 2018-10-23 |
EA201891647A1 (en) | 2018-12-28 |
RU2620855C1 (en) | 2017-05-30 |
KR20180101539A (en) | 2018-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL256085B (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
ZA201907158B (en) | Methods and compositions for treating sleep apnea | |
HRP20210518T1 (en) | 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders | |
IL269174A (en) | Methods for treating complement-mediated diseases and disorders | |
HK1258696A1 (en) | Novel compositions and methods for treating or preventing dermal disorders | |
ZA201901055B (en) | Treatment and prevention of sleep disorders | |
PL3362449T3 (en) | Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis | |
HK1252813A1 (en) | Therapeutic compounds and compositions for treating social disorders and substance use disorders | |
HK1257935A1 (en) | Aminoglycoside derivatives and uses thereof in treating genetic disorders | |
EP3677265A4 (en) | Composition for preventing or treating sleep disorders | |
HK1257587A1 (en) | Medicine for preventing and treating liver fibrosis and use of the medicine | |
IL250114A0 (en) | Methods and compositions for treating hiv-related disorders | |
EP3262065C0 (en) | Methods and compositions for treating dystroglycanopathy disorders | |
IL280389A (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
PT3290051T (en) | Pharmaceutical composition for treating and/or preventing cancer | |
PT3236961T (en) | Pharmaceutical composition for preventing or treating cancer and method using thereof | |
GB201519644D0 (en) | Therapy and pharmaceutical composition | |
PL3650024T3 (en) | Pharmaceutical composition for nasal administration comprising rifampicins for treating dementia | |
EP3552632A4 (en) | Medicinal composition for treating and preventing chronic disease | |
HK1255631A1 (en) | Pharmaceutical composition for preventing and treating sleep disorders | |
AU2017902338A0 (en) | Sleep Disorder Composition and Treatment Thereof | |
AU2015902659A0 (en) | Therapeutic compounds and compositions for treating social disorders and substance use disorders |